AAIC 2025 Abstract
Reference proteins to improve performance of core 1 and core 2 Alzheimer's disease CSF and plasma biomarkers
Study in peopleBiomarkers
Abstract
Background: Concentration‐based fluid biomarkers represent an informative and cost‐effective way to detect and monitor Alzheimer's disease (AD) pathology. However, non‐AD‐related inter‐individual variation in biofluids can also affect biomarker concentrations.
